Service description and background. This service is commissioned as a local enhanced service under the powers given to NHS England by The Pharmaceutical Services (Advanced and Enhanced Services) (England) Directions 2013 paragraph 14 (1) (h) and (o). Community Pharmacists will contribute to the reduction of prescribed unwanted medicines, which currently are wasted. This service will be undertaken at the point of dispensing. This will help to prevent patient’s stockpiling of prescribed medicines and reduce inefficiencies in prescribing on FP10s. The service will inform GP repeat prescribing processes thus contributing to improved patient outcomes through harm reduction, reduced hospital admissions, and increased medicine concordance. It is expected that the service will encourage Pharmacists to carry out Medicine Use Reviews (MUR) with patients who they have identified as having issues with their prescribed medicines or processes around ordering repeat medicines. The object of this scheme is to reduce the burden of waste medicines, which has far reaching implications both financially and in terms of harm and health outcomes for patients: To reduce the number of unwanted medicines dispensed and therefore wasted, by not dispensing items not required by the patient. To notify the prescriber when an item prescribed has not been dispensed. To promote, support and encourage good repeat / prescribing practices with patients and GP practices. To highlight under usage of medicines to the prescriber. To inform the prescriber whether the continued supply or non-supply of items would be considered clinically significant. To highlight prescribing inefficiencies to the prescriber. To reduce unnecessary prescribing costs.
Appears in 6 contracts
Samples: Service Level Agreement, Service Level Agreement, Service Level Agreement
Service description and background. This service is commissioned as a local enhanced service under the powers given to NHS England by The Pharmaceutical Services (Advanced and Enhanced Services) (England) Directions 2013 paragraph 14 (1) (h) and (o). Community Pharmacists will contribute to the reduction of prescribed unwanted medicines, which currently are wasted. This service will be undertaken at the point of dispensing. This will help to prevent patient’s stockpiling of prescribed medicines and reduce inefficiencies in prescribing on FP10s. The service will inform GP repeat prescribing processes thus contributing to improved patient outcomes through harm reduction, reduced hospital admissions, and increased medicine concordance. It is expected that the service will encourage Pharmacists to carry out Medicine Use Reviews (MUR) with patients who they have identified as having issues with their prescribed medicines or processes around ordering repeat medicines. The object of this scheme is to reduce the burden of waste medicines, which has far reaching implications both financially and in terms of harm and health outcomes for patients: • To reduce the number of unwanted medicines dispensed and therefore wasted, by not dispensing items not required by the patient. • To notify the prescriber when an item prescribed has not been dispensed. • To promote, support and encourage good repeat / prescribing practices with patients and GP practices. • To highlight under usage of medicines to the prescriber. • To inform the prescriber whether the continued supply or non-supply of items would be considered clinically significant. • To highlight prescribing inefficiencies to the prescriber. • To reduce unnecessary prescribing costs.
Appears in 1 contract
Samples: Service Level Agreement